Editor—Our paper on the duration of breast feeding and later arterial distensibility evoked much comment, especially from those who promote breast feeding. Unfortunately the media coverage may have deflected attention from the cautious way we framed our findings—and our clear recommendation that they should not change breastfeeding practice.
Some cast doubt on our work by implying that it was motivated or influenced by formula milk companies. This is certainly not so. The study was funded by the Medical Research Council and the university, with no industrial connection whatsoever. Our childhood nutrition centre is core funded by the government (MRC). Our longstanding research includes some of the strongest scientific evidence available favouring breast feeding, in terms of its beneficial effects on cognitive development, blood pressure, bone health, atopic disease, infection, gut disease, and catch-up growth7-1,7-2—evidence much used by professional organisations that support breast feeding. We have also researched the efficacy and safety of new advances in infant formula milks and, for transparency, cite this in our article. As an independent centre we publish what we find in the interests of public health, quite regardless of any pressures from either industry or advocacy groups.
Our findings have clearly seemed counterintuitive to many. Dettwyler cites an anthropological argument based on primate work, that humans were evolved to breast-feed for two and a half to seven years, as evidence that our results are biologically implausible. Life span was, however, much shorter when human lactation evolved, and we cannot assume that breast feeding, through past evolution, would now confer any advantage in terms of reduced adult degenerative disease or postreproductive survival. Nor can we assume that breast feeding evolved such that humans would necessarily be well adapted to a modern Western style post-weaning diet. Holmes affirms this view.
Our paper has stimulated comment on interpretation and methods. We agree with Greiner that it is difficult to interpret non-randomised outcome studies on breastfed infants, which of course also applies to the extensive and potentially confounded literature purporting to show benefits of breast feeding. This centre has been one of the only ones to conduct large scale randomised studies on breast milk versus formula in a circumstance in which this is ethical—in non-breastfed premature infants who can be assigned randomly to formula milk or donated banked breast milk. These few studies provide experimental evidence for long term effects of breast milk on health outcomes.7-1 When randomisation is precluded (as, say, with smoking), however, causation must be established from a weight of epidemiological evidence, supported by animal experiments. We appraised the possible significance of our own data in such a context, although we accept that the research is at an early stage.
Some respondents imply that we were directly comparing formula feeding to breast feeding. This was not our intention. As Holt noted, formula milks used in the 1970s were different from those currently available, and study of formula fed subjects in our cohort would have had little contemporary relevance. In epidemiological and intervention studies, breast feeding seems to confer cardiovascular benefit over formula feeding.7-1 Our interest focused solely on the duration of breast feeding in relation to vascular health in a Western population, in view of previous work we reference.
Our paper considers carefully our surrogate marker of arterial disease, brachial artery distensibility. Wilkinson and Cockroft note that much work on distensibility has been based on the widely used aortic pulse wave velocity. Oddly, their response entirely ignores more recent studies, including this paper, which consistently show an association between peripheral artery distensibility and concentrations of cholesterol—and that the various methods for measuring distensibility in central and peripheral arteries are well intercorrelated.7-3–7-6 Simple non-invasive vascular measures, as used in our study, provide unique opportunities to investigate early stages of disease development.
We used a statistically robust approach to data analysis and have been appropriately cautious in our interpretation, taking account of cohort size and significance level. We would reassure Dark and Rölli that the relation between breastfeeding duration and arterial distensibility persists whether analysis is performed on the entire cohort or solely on those breast fed. The r2 for distensibility versus length of breast feeding is 0.22, suggesting the model accounts for around a quarter of the variability in distensibility.
Finally, we wish to re-emphasise why we would not suggest any current change in breast feeding practice. Firstly, our data are at too early a stage to be translated into health policy. Secondly, any risk-benefit analysis must include the many positive purported benefits of breast feeding on short and long term outcome.
If the hypothesis we raised proves correct, that more prolonged breastfeeding duration followed by a Western style diet explains our results, then future intervention policy might be better directed to our Western diet rather than breast feeding. We hope that the complex social issues that surround this subject will not cloud the need for dispassionate research to optimise infant nutrition in relation to long term health.
Footnotes
Competing interests: The centre has collaborated with the infant food industry for its outcome studies on nutrition.
References
-
7-1.Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet. 2001;357:413–419. doi: 10.1016/S0140-6736(00)04004-6. [DOI] [PubMed] [Google Scholar]
-
7-2.Lucas A, Morley RM, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet. 1992;339:261–264. doi: 10.1016/0140-6736(92)91329-7. [DOI] [PubMed] [Google Scholar]
-
7-3.Leeson CP, Whincup PH, Cook DG, Mullen MJ, Donald AF, Seymour CA, et al. Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation. 2000;101:1533–1538. doi: 10.1161/01.cir.101.13.1533. [DOI] [PubMed] [Google Scholar]
-
7-4.Giannattasio C, Mangoni AA, Failla M, Carugo S, Stella ML, Stefanoni P, et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolaemia. Atherosclerosis. 1996;124:249–260. doi: 10.1016/0021-9150(96)05834-0. [DOI] [PubMed] [Google Scholar]
-
7-5.Shiage H, Dart A, Nestel P. Simvastatin improves arterial compliance in the lower limb but not in the aorta. Atherosclerosis. 2001;155:245–250. doi: 10.1016/s0021-9150(00)00558-x. [DOI] [PubMed] [Google Scholar]
-
7-6.Liang YL, Teede H, Kotsopoulos D, Shiel L, Cameron JD, Dart AM, et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci. 1998;95:669–679. doi: 10.1042/cs0950669. [DOI] [PubMed] [Google Scholar]